Form 8-K PTC THERAPEUTICS, INC. For: May 20
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St futures subdued as investors weigh earnings, oil prices
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil prices hit fresh 6-week highs on renewed Middle East tensions
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
PTC Therapeutics (PTCT) PT Raised to $32 at Goldman Sachs, Reiterates Sell
May 20, 2024 2:29 PM EDTGoldman Sachs analyst Paul Choi raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $32.00 (from $18.00) while maintaining a Sell rating.
The analyst comments "The European Commission decided not to adopt and seeks a re-evaluation of the CHMP's negative opinion on Translarna;... More
PTC Therapeutics (PTCT) PT Raised to $46 at Jefferies
May 20, 2024 12:29 PM EDTJefferies analyst Kelly Shi raised the price target on PTC Therapeutics (NASDAQ: PTCT) to $46.00 (from $35.00) while maintaining a Buy rating.
The analyst comments "We had 1x1 with mgmt after the unexpected PR of CHMP re-evaluation of Translarna. The only precedent was Glybera... More
